Steven d. Schwartz

Executive

US·SEC (Form 4)

Bio-Rad Laboratories, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€134k

Latest filing published 28 Aug 2024 for Bio-Rad Laboratories, INC.. Read the official filing

Filing timeline

BuySale

Steven d. Schwartz

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Steven d. Schwartz: trading record in brief

All filings by Steven d. Schwartz on record concern Bio-Rad Laboratories, Inc., in the capacity of chief executive. Between 9 November 2021 and 26 August 2024, the trades on record add up to 5 filings.

The open-market record consists of 1 sale worth €134k, with no purchase. 2024 to date brings no purchases and 1 sale.

The newest entry dates from 28 August 2024: a transaction, in Bio-Rad Laboratories, Inc. Filings reach the SEC (Form 4) feed a median of 14 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.